{
  "casebody": {
    "data": "<casebody firstpage=\"918\" lastpage=\"919\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties data-order=\"0\" data-type=\"parties\" id=\"b942-7\">FARMAMEDICA, S.A., Plaintiff-Appellee, v. Ana Eloisa Alfaron DE MARON, d.b.a. Combisa Laboratorios, Defendant-Appellant.</parties>\n<docketnumber data-order=\"1\" data-type=\"docketnumber\" id=\"b942-10\">No. 11-13578</docketnumber>\n<p data-order=\"2\" data-type=\"summary\" id=\"A41\">Non-Argument Calendar.</p>\n<court data-order=\"3\" data-type=\"court\" id=\"b942-11\">United States Court of Appeals, Eleventh Circuit.</court>\n<decisiondate data-order=\"4\" data-type=\"decisiondate\" id=\"b942-12\">March 20, 2012.</decisiondate>\n<attorneys data-order=\"5\" data-type=\"attorneys\" id=\"b942-13\">Michelle L. Mejia, Gilbert Lee Sandler, Sandler Travis &amp; Rosenberg, PA, Miami, FL, Kenneth N. Wolf, Sandler Travis &amp; Rosenberg, PA, New York, NY, for Plaintiff-Appellee.</attorneys>\n<attorneys data-order=\"6\" data-type=\"attorneys\" id=\"b942-16\">Stephen D. Milbrath, Robert Houpt Thornburg, Allen Dyer Doppelt Milbrath &amp; Gilchrist, PA, Orlando, FL, for Defendant-Appellant.</attorneys>\n<judges data-order=\"7\" data-type=\"judges\" id=\"b942-18\">Before CARNES, WILSON and HILL, Circuit Judges.</judges>\n<opinion data-order=\"8\" data-type=\"opinion\" id=\"x999-1\" type=\"majority\">\n<author id=\"b942-19\">PER CURIAM:</author>\n<p id=\"b942-20\">Plaintiff-Appellee Farmamedica, S.A. (Farmamedica), alleged that Defendant-Appellant Ana Eloisa Aliaron de Mar\u00f3n d/b/a Combisa Laboratorios (de Mar\u00f3n) infringed upon its trademark \u201cVital Fuerte\u201d when she used the mark \u201cSuper Vital Forte.\u201d In 2007, de Maron\u2019s attorney made an offer of settlement.<footnotemark>1</footnotemark> Farmamedi-ca accepted the offer. Final judgment was entered. A permanent injunction issued against de Mar\u00f3n from using the mark \u201cSuper Vital Forte.\u201d</p>\n<p id=\"b942-21\">In 2008, de Mar\u00f3n applied to register the mark \u201cSupervitalforte.\u201d In 2009, Far-mamedica moved for contempt. In 2011, forty-two (42) months after judgment was entered against her, de Mar\u00f3n filed a motion for relief from judgment under Rule 60(b), and Farmamedica renewed its motion for contempt. The district court denied de Maron\u2019s motion for relief from judgment, and granted in part, Far-mamedica\u2019s renewed motion for contempt.</p>\n<p id=\"b943-4\"><page-number citation-index=\"1\" label=\"919\">*919</page-number>We have reviewed the record in this appeal, the briefs and the arguments of counsel. The July 14, 2011, order of the district court is thorough and well-reasoned. Finding no error, we affirm the judgment of the district court.</p>\n<p id=\"A3J\">AFFIRMED.</p>\n<footnote label=\"1\">\n<p id=\"b942-14\">. De Mar\u00f3n claims now that she did not give her attorney authority to settle in 2007. The district court assumed that de Maron's former attorney lacked the authority to settle, therefore, de Maron's motion requesting an eviden-tiary hearing on this factual dispute, was denied as moot.</p>\n</footnote>\n</opinion>\n</casebody>\n",
    "status": "ok"
  }
}